February 2026: New Health Care Technology Standards Revolutionize Device Quality, Diagnostics, and TCM

Advancements in health care technology continue at a rapid pace, with February 2026 marking the release of four pivotal international standards. These latest publications address crucial concerns—from the global trade and safe use of traditional herbal medicines, to the precision of molecular diagnostics, modern surgical instruments, and the lifecycle management of medical devices in healthcare settings. Professionals in clinical, technical, regulatory, and procurement roles will find these updates essential for optimizing safety, efficiency, and compliance in the ever-evolving health care sector.

Overview

The health care technology sector is navigating an era of rigorous global harmonization, where international standards define not only product quality, but also organizational processes, patient safety, and market access. With growing complexity in patient care, diagnostics, and therapeutic devices, standards ensure interoperability, safety, reliability, and consistency across borders. In this article, you will gain:

• An in-depth understanding of four influential standards published in February 2026
• Actionable compliance guidance
• Insight into the practical implications for manufacturers, laboratories, and healthcare delivery organizations (HDOs)
• Essential takeaways for quality and risk management in procurement and operational practice

Detailed Standards Coverage

ISO 25003:2026 – Traditional Chinese Medicine: Gentiana scabra, Gentiana manshurica, and Gentiana triflora Root and Rhizome

Traditional Chinese medicine — Gentiana scabra, Gentiana manshurica, and Gentiana triflora root and rhizome

This groundbreaking standard addresses the need for international harmonization in quality and safety of Gentiana scabra, Gentiana manshurica, and Gentiana triflora root and rhizome. Widely known as 'Longdan', these roots hold significant therapeutic value and are extensively used in Traditional Chinese Medicine (TCM) across China, Japan, Korea, and international trade.

Major Requirements and Specifications

• Morphological and microscopic identification criteria for root and rhizome
• Rigorous thresholds for moisture, total ash, acid-insoluble ash, and water-soluble extractives
• Advanced marker compound content verification, notably gentiopicroside
• Acceptance limits for heavy metals (arsenic, mercury, lead, cadmium)
• Pesticide residue and sulfur dioxide content determination
• Guidelines for thin-layer chromatographic (TLC) identification
• Prescriptive instructions for sampling, packaging, storage (ISO 22217), and labelling (ISO 21371)

Who Should Comply?

• Manufacturers and exporters of Gentiana raw materials
• International traders and buyers of TCM herbal ingredients
• Quality managers and compliance officers in herbal medicine supply chains

Practical Implications

This standard unifies disparate national requirements, facilitating international trade while safeguarding patient safety and clinical outcomes. Laboratories benefit from standardized testing methods, and procurement teams can ensure uniformity in product specifications and supplier assessments.

Key highlights:

• Unified international quality and safety requirements for Gentiana roots
• Standardized test procedures and identification markers
• Enhanced traceability from raw material to finished product

Access the full standard:View ISO 25003:2026 on iTeh Standards

ISO 6335-2:2026 – Surgical Instruments: Staplers — Part 2: General Requirements

Surgical instruments — Staplers — Part 2: General requirements

ISO 6335-2:2026 establishes comprehensive benchmarks for all surgical staplers, whether single-use or reusable. The standard covers the lifecycle from design specification to post-market surveillance, addressing critical aspects of both safety and performance.

Scope and Core Requirements

• Classification and intended use of stapler types
• Essential design attributes and ergonomic considerations
• Selection of safe and biocompatible materials (referencing ISO 5832-2, 10993 series)
• Structured methodologies for design evaluation: pre-clinical and clinical trials, post-market analysis
• Detailed manufacturing and quality control criteria
• Stringent sterilization protocols (ISO 11135, 11137, 17665)
• Packaging systems to maintain integrity and sterility (ISO 11607)
• Explicit manufacturer information: labelling, instructions for use, and combination restrictions

Applicability

• Surgical instrument manufacturers and OEMs
• Health care providers and hospital procurement departments
• Regulatory and quality compliance specialists

Implementation Insights

By mandating thorough design evaluation and robust sterilization controls, ISO 6335-2 mitigates device-related risks during surgery, supports regulatory clearance, and drives greater confidence among end users. The standard enhances post-market vigilance and feedback loops for continuous improvement.

Key highlights:

• Universal requirements for safe, effective use of surgical staplers
• Emphasis on biological evaluation, risk management, and sterilization
• Detailed documentation and labelling for traceability and safe operation

Access the full standard:View ISO 6335-2:2026 on iTeh Standards

ISO/TS 5137:2026 – Medical Device Maintenance Management Programme for Healthcare Delivery Organizations (HDOs)

Medical device maintenance management programme for healthcare delivery organizations (HDO)

ISO/TS 5137:2026 advances the quality and safety infrastructure for medical device maintenance within health care delivery organizations. It offers a structured, top-level framework for the realization, measurement, and ongoing improvement of device maintenance, aligning well with ISO 13485 and ISO 9001.

Key Requirements and Management Focus

• Documentation of a comprehensive maintenance management program
• Delineation of responsibilities between HDOs and biomedical engineering services (BES)
• Detailed process controls for:
  • Preventive, user, routine, predictive, and unscheduled maintenance
  • Testing, commissioning, acceptance, release for service
  • Decommissioning and disposal of medical devices
  • Spare parts management
• Performance measurement, data analysis, control of nonconforming devices
• Systems for alert and recall notices, adverse incident reporting
• Internal audits, training, and advisory services

Who Needs to Comply?

• Hospitals, clinics, and any health care provider operating reusable medical devices
• Biomedical engineering departments and third-party service providers
• HDO quality and risk management teams overseeing maintenance standards

Implementation Considerations

By introducing a rigorous, process-driven maintenance framework, this standard minimizes device downtime, prevents adverse patient outcomes, and assures regulatory readiness. It is especially relevant for HDOs seeking ISO 13485 certification or integrating their maintenance program into a quality management system.

Key highlights:

• Comprehensive approach to life-cycle maintenance of medical devices
• Strong alignment with risk management and data-driven improvement
• Clear documentation, audit, and compliance pathways for healthcare organizations

Access the full standard:View ISO/TS 5137:2026 on iTeh Standards

ISO 18704:2026 – Molecular In Vitro Diagnostic Examinations: Pre-Examination Process for Cell-Free DNA from Urine and Other Body Fluids

Molecular in vitro diagnostic examinations — Requirements and recommendations for pre-examination processes for urine and other body fluids — Isolated cell-free DNA

ISO 18704:2026 is a major advancement for laboratories, biobanks, and manufacturers in the rapidly growing field of molecular diagnostics. The standard specifies precise, comprehensive processes for the collection, handling, transport, isolation, and storage of cell-free DNA (cfDNA) from human fluids other than blood.

What the Standard Covers

• Information and procedures for specimen donor identification and data collection
• Selection and validation of collection devices and use of cfDNA stabilizers
• Defined protocols for collection, storage, and transport of specimens (urine, saliva, CSF, pleural fluid, ascites)
• Laboratory processing, including centrifugation, purification, isolation, and documentation
• Procedures for isolation using both commercial kits and laboratory-developed methods
• Recommended test performance, cfDNA quantity and quality assessments
• Storage standards for both pre- and post-isolation material

Target Users

• Medical and diagnostic laboratories
• Health institutions engaged in specimen collection, storage, and analysis
• In vitro diagnostic (IVD) developers and manufacturers
• Biobanks and biomedical research institutions
• Regulatory authorities

Practical Implications

Standardization of cfDNA handling minimizes pre-analytical errors, improves result accuracy and sensitivity for genetic testing and cancer biomarker analysis, and underpins compliance with ISO 15189 and ISO 13485. This has significant implications for translational research, routine clinical diagnostics, and the development of innovative IVD products.

Key highlights:

• Comprehensive pre-examination workflow minimizes sample degradation
• Consistent protocols for specimen and cfDNA processing
• Supports advanced diagnostics and regulatory compliance

Access the full standard:View ISO 18704:2026 on iTeh Standards

Industry Impact & Compliance

The four standards released this month reflect a broader trend toward global convergence, transparency, and heightened accountability in health care technology. Their adoption offers:

• Improved interoperability and quality in international supply chains
• Reduced market entry barriers through harmonized requirements
• Clearly defined manufacturer and end-user responsibilities, minimizing errors
• Evidence-based best practices for patient safety and regulatory compliance

Compliance strategies:

• Early engagement: Identify gaps in current processes and specifications
• Training for key personnel on new testing, labelling, and operational protocols
• Update supplier agreements and procurement specifications
• Timely risk assessments and documentation updates to satisfy audits

Failure to comply may result in regulatory sanctions, product recalls, or patient safety incidents—costs that can be substantially higher than proactive compliance investment.

Technical Insights

Common Technical Themes

• Rigorous documentation and traceability requirements across all standards
• Emphasis on biological, chemical, and process validation
• Alignment with major international references (ISO 13485, 15189, 9001, 11607, 22217, and 21371)
• Objective evidence and reporting mechanisms for every key activity

Implementation Best Practices

1. Gap Analysis: Map existing practices against each clause and requirement of the new standards.
2. Process Integration: Incorporate new test methods, quality benchmarks, and reporting procedures.
3. Training: Ensure staff are familiar with updated protocols, especially for new laboratory, packaging, sterilization, or maintenance requirements.
4. Supplier and Vendor Management: Audit upstream suppliers to verify readiness and compliance with standardized requirements—particularly for herbal medicines, surgical devices, and laboratory consumables.
5. Ongoing Review: Implement continuous improvement and feedback mechanisms, supported by internal audits and regular risk assessment.

Testing and Certification Considerations

• Laboratories and manufacturers should consider third-party certification against ISO standards (especially ISO 13485 and 15189) for competitive advantage.
• Mastery of new test and verification methods (e.g., HPLC-UV for herbal marker compounds, advanced sterilization validation, and pre-analytical laboratory workflows) is essential for accreditation and regulatory approval.

Conclusion & Next Steps

The February 2026 portfolio of health care technology standards signals a new benchmark for quality, safety, and operational excellence. Organizations across manufacturing, clinical delivery, and diagnostics are encouraged to:

• Conduct comprehensive reviews of the new standards and their specifications
• Update internal SOPs, procurement policies, and supplier contracts accordingly
• Provide targeted training to ensure smooth transitions
• Leverage the detailed requirements to drive internal quality, reduce risk, and streamline compliance audits

Explore these new standards in detail and stay tuned via iTeh Standards for updates, guidance, and expert insights that keep your organization ahead of regulatory and market demands.